4Loot F, Tiberghien F, Wenandy T, et al. Cyclosporins: struture-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter. J Med Chem,2002,45(21):4598.
5Meaden ER, Hoggard PG, Khoo SH, et al. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J Immunol Methods,2002,262(1-2):159.
6Dhar S, Nygren P, Liminga G, et al. Relationship between cytotoxic drug response patterns and activity of drug efflux transporters mediating multidrug resistance. Eur J Pharmacol, 1998,346(2-3):315.
7Toffoli G, Simone F, Corona G, et al. Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. Biochem Pharmacol, 1995,50:1245.
9Versantvoort CH, Bagrij T, Wright KA, et al. On the rela tio ship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int J Cancer, 1995,63(6):855.
10Legrand O, Simonin G, Perrot JY, et al. Both Pgp and MRP1 activities using calcein-AM contribute to drug resistance in AML. Adv Exp Med Biol, 1999,457:161.
